Theratechnologies Valor da empresa
Qual é o Valor da empresa de Theratechnologies?
O Valor da empresa de Theratechnologies, Inc. é $125.30M
Qual é a definição de Valor da empresa?
O valor da empresa é uma medida do valor total de mercado de uma empresa. É calculado como capitalização de mercado com dívida, participação minoritária e ações preferenciais menos o total de caixa e equivalentes de caixa.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Valor da empresa de empresas na Setor Health Care em TSX em comparação com Theratechnologies
O que Theratechnologies faz?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Empresas com valor da empresa semelhantes a Theratechnologies
- Litigation Capital Management tem Valor da empresa de $125.07M
- Freegold Ventures tem Valor da empresa de $125.09M
- Jericho Oil tem Valor da empresa de $125.09M
- Skylight Health tem Valor da empresa de $125.13M
- Jinhui tem Valor da empresa de $125.20M
- Anpario plc tem Valor da empresa de $125.23M
- Theratechnologies tem Valor da empresa de $125.30M
- Lippo China Resources tem Valor da empresa de $125.32M
- Galena Mining tem Valor da empresa de $125.37M
- AFC plc tem Valor da empresa de $125.43M
- Georgia Healthcare Plc tem Valor da empresa de $125.45M
- Sportking India tem Valor da empresa de $125.72M
- Manolete Partners Plc tem Valor da empresa de $125.82M